A detailed analyses of pancreatic cancer patient samples indicated that Haspin is upregulated in its expression and activity in 55% of analyzed cases of PDA (Fig. 3A,B), and that increased expression of Haspin can be correlated with decreased overall patient survival (Fig. 3C). Here, HASPIN is linked to Patent ductus arteriosus.